App-Quantinova.ai

Polymorphism of genes associated with fibrin clot structure or/and lysis rate could influence the risk of pulmonary embolism in young patients with venous thromboembolism

A. Chechulova - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Poor Performance Status and Elevated Factor VIII Levels Increase Thrombotic Risk in Lymphoma and Multiple Myeloma Patients

I. S�nchez Prieto - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

FVIII

Population-based reference ranges of platelet function tests and their discriminative ability for cardiovascular disease

S. von Ungern-Sternberg - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Post-Menopausal Bleeding and Arterial Thrombosis in Biological Females with Inherited Bleeding Disorders

G. Moyer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Post-Operative Bleeding and Thrombosis in Biological Females with Inherited Bleeding Disorders: A Cross-Sectional Analysis from the Community Counts Registry

G. Moyer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Post-thrombotic syndrome in patients with venous thromboembolism treated with rivaroxaban – Results from the FIRST Registry

V. Speed - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

Potential utility of a multi-component coagulation factor panel to detect portal vein thrombosis and assess hemostasis in chronic liver disease

C. Lewis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

FVIII

PPAR-alpha inhibition of platelet activation and thrombosis

L. Stanger - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Pre-Operative Thromboprophylaxis Does Not Cause Increased Bleeding Events in Patients with Surgically-Treated Hip Fractures

H. Krzyzaniak - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Pre-surgical ovarian vein thrombosis in women with ovarian malignancies as predictor of pulmonary embolism

H. Wiegers - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predicting post-discharge venous thromboembolism and major bleeding among medical patients: External validation of a risk score derived from readily available laboratory tests.

S. Hyder - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prediction of bleeding risk in patients with cancer receiving anticoagulants

E. Trinks-Roerdink - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Predictive factors of clot propagation towards deep venous thrombosis and/or pulmonary embolism in superficial venous thrombosis patients: a systematic review

F. van Royen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predictive value of Wells and Geneva score in suspected pulmonary thromboembolism in critically ill patients with COVID 19: A Retrospective Study

N. Diaconu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predictors of Catheter-related Arterial Thrombosis in Pediatric Patients After Cardiac Catheterization

R. Natesirinilkul - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Predictors of Pregnancy Associated Venous Thromboembolism: A Case-Control Study

M. AlSheef - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predictors of venous thromboembolism in hospitalised COVID-19 positive patients

P. MacCallum - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prevalence and Impact of Antiphospholipid Antibodies on Thrombotic Events in Ambulatory Cancer Patients

C. Kansuttiviwat - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prevalence of venous thromboembolism and its associations with demographics, disease spectrum and hydroxyurea use in a large racially homogenous population of sickle cell disease patients in Nigeria

H. Okoye - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hydroxyurea

Prevention of Upper Extremity PICC-associated Thrombosis Using Squeeze Balls in the Inpatient Oncology Setting: Preliminary Findings from a Prospective Single-Arm Non-Randomized Investigation

E. Harris - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts